1. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease;Doody;Archives of Neurology,2001
2. Feldman H. Gauthier S. Hecker J. Vellas B. Subbiah P. Whalen E. Donepezil MSAD Study Investigators Group Erratum: a 24-week, randomized, double-blind study of donepezil in moderate to severe alzheimer's disease Neurology 2001 2153
3. Donepezil lengthens time to loss of activities of daily living in patients with mild to moderate Alzheimer's disease - results of a preliminary evaluation. Presented at the annual meeting of the American Academy of Neurology. Boston;Friedhoff;Neurology,1997
4. Friedhoff LT Rogers SL Donepezil lengthens time to loss of activities of daily living and cognition in patients with mild to moderate Alzheimer's disease Proceedings of the 10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17, Vienna, Austria 1997 SR-HANDSRCH
5. Donepezil maintains activities of daily living in patients with mild to moderately severe Alzheimer's disease: results of a retrospective analysis;Friedhoff;Eur J Neurology,1997